Neuropharmacological insights into Gardenia jasminoides Ellis: Harnessing therapeutic potential for central nervous system disorders

• Published in: Phytomedicine (Stuttgart) 2024-03, Vol.125, p.155374, Article 155374
• Main Authors: Hou, Ziyu, Sun, Le, Jiang, Zheyu, Zeng, Tiexin, Wu, Peiling, Huang, Jiali, Liu, Haibo, Xiao, Peigen
• Format: Article
• Language: English
• Subjects: Central nervous system disorders; Gardenia jasminoides Ellis; Intestinal flora; mechanism of action; Network pharmacology
• ISSN: 0944-7113; 1618-095X; 1618-095X
• DOI: 10.1016/j.phymed.2024.155374

In China, Gardenia jasminoides Ellis (GJE) has a longstanding history of application. The Ministry of Health has listed it as one of the first pharmaceutical or food resources. In ethnic, traditional, and folk medicine, GJE has been used to treat fever and cold and relieve nervous anxiety. Recent studies have confirmed the significant efficacy of GJE for treating central nervous system (CNS) disorders, including Alzheimer's disease, Parkinson's disease, and major depressive disorder; however, GJE has not been systematically evaluated. This research systematically summarizes global studies on the use of GJE for treating CNS disorders and explores the potential applications and underlying mechanisms via intestinal flora analysis and network pharmacology, aiming to establish a scientific basis for innovative CNS disorder treatment with GJE. The PRISMA guidelines were used, and electronic databases such as the Web of Science, PubMed, and China National Knowledge Infrastructure were searched using the following search terms: “Gardenia jasminoides Ellis” with “central nervous system disease,” “neuroprotection,” “Alzheimer's disease,” “Parkinson's disease,” “ischemic stroke,” “Epilepsy,” and “major depressive disorder.” The published literature up to September 2023 was searched to obtain relevant information on the application of GJE for treating CNS disorders. There has been an increase in research on the material formulation and mechanisms of action of GJE for treating CNS disorders, with marked effects on CNS disorder treatment in different countries and regions. We summarized the research results related to the role of GJE in vitro and in vivo via multitargeted interventions in response to the complex mechanisms of action of CNS disorders. We systematically reviewed the research progress on traditional treatment for GJE and preclinical mechanisms of CNS disorders and explored the potential of optimizing network pharmacology strategies and intestinal flora analysis to elucidate the mechanisms of action of GJE. The remarkable therapeutic efficacy of GJE, an important resource in traditional medicine, has been well documented in the literature, highlighting its significant medicinal potential. In-depth analysis of different pathological mechanisms of Gardenia jasminoides Ellis and its natural products in the treatment of central nervous system diseases and prospects for new mechanisms of intestinal flora and network pharmacology. [Display omitted]